NURS 6521 Week-9 Quiz, NURS 6521 Advanced
Pharmacology,
Question 1
1 out of 1 points
A patient will soon begin targeted therapy as a component of her
treatment plan for chronic leukemia. The nurse is conducting health
education about this new aspect of the patient's drug regimen and the
patient has asked about the potential side effects of treatment. How
should the nurse best respond?
Response Targeted therapies are generally considered to be less
Feedback: toxic than traditional chemotherapy drugs. However,
adverse reactions to targeted therapies can occur such as
severe skin reactions, GI toxicities, skin reactions, and
thrombosis.
Question 2
1 out of 1 points
Mr. Singh is a 66-year-old man who is receiving chemotherapy for the
treatment of lung cancer that has metastasized to his liver. In an effort
to prevent infection, Mr. Singh has been prescribed filgrastim
(Neupogen). Which of the nurse's following assessment questions
most directly addresses a common adverse effect of filgrastim?
Response Medullary bone pain is a consistently observed adverse
Feedback: effect that can be attributed to drug therapy with
filgrastim; it is mild to moderate in severity and is
reported in 56% of patients taking the drug. Shortness of
breath, mucosal bleeding, and cool, clammy skin are not
adverse effects typical of filgrastim.
Question 3
1 out of 1 points
An older adult woman has been diagnosed with acute lymphoblastic
leukemia (ALL) and her care team has identified potential benefits of
imatinib. Which of the following characteristics of this patient's
current health status may preclude the use of imatinib?
, Response Imatinib may be associated with edema. Patients should
Feedback: be weighed regularly and assessed for signs of fluid
retention that could be severe. The risk of edema
increases with higher doses of imatinib and age greater
than 65 years. Previous strokes, orthopedic surgery, or
well-controlled diabetes may not contraindicate the use
of imatinib.
Question 4
1 out of 1 points
An oncology nurse is reviewing the pathophysiology of cancer and is
discussing with a colleague the factors that contribute to the success or
failure of a patient's chemotherapy. Which of the following cancerous
cells is most susceptible to the effects of chemotherapeutic drugs?
Response Cells that have a short generation time or rapid mitotic
Feedback: rate are most sensitive to antineoplastic agents. All cells
(both cancerous and noncancerous) have a blood supply.
A lack of contact inhibition is characteristic of cancer,
but this is not associated with susceptibility to
chemotherapeutic drugs.
Question 5
1 out of 1 points
A nurse is caring for a patient with cancer who has been prescribed
dronabinol (Marinol) to help reduce nausea and vomiting from
chemotherapy. The nurse will inform the patient that he or she is
taking an oral form of
Response The major ingredient of Marinol is 9-
Feedback: tetrahydrocannabinol (THC), the active ingredient in
marijuana.
Question 6
1 out of 1 points
When planning care for a patient who is receiving filgrastim
(Neupogen) for a nonmyeloid malignancy, the nurse should formulate
which of the following patient outcomes? (Select all that apply.)
Pharmacology,
Question 1
1 out of 1 points
A patient will soon begin targeted therapy as a component of her
treatment plan for chronic leukemia. The nurse is conducting health
education about this new aspect of the patient's drug regimen and the
patient has asked about the potential side effects of treatment. How
should the nurse best respond?
Response Targeted therapies are generally considered to be less
Feedback: toxic than traditional chemotherapy drugs. However,
adverse reactions to targeted therapies can occur such as
severe skin reactions, GI toxicities, skin reactions, and
thrombosis.
Question 2
1 out of 1 points
Mr. Singh is a 66-year-old man who is receiving chemotherapy for the
treatment of lung cancer that has metastasized to his liver. In an effort
to prevent infection, Mr. Singh has been prescribed filgrastim
(Neupogen). Which of the nurse's following assessment questions
most directly addresses a common adverse effect of filgrastim?
Response Medullary bone pain is a consistently observed adverse
Feedback: effect that can be attributed to drug therapy with
filgrastim; it is mild to moderate in severity and is
reported in 56% of patients taking the drug. Shortness of
breath, mucosal bleeding, and cool, clammy skin are not
adverse effects typical of filgrastim.
Question 3
1 out of 1 points
An older adult woman has been diagnosed with acute lymphoblastic
leukemia (ALL) and her care team has identified potential benefits of
imatinib. Which of the following characteristics of this patient's
current health status may preclude the use of imatinib?
, Response Imatinib may be associated with edema. Patients should
Feedback: be weighed regularly and assessed for signs of fluid
retention that could be severe. The risk of edema
increases with higher doses of imatinib and age greater
than 65 years. Previous strokes, orthopedic surgery, or
well-controlled diabetes may not contraindicate the use
of imatinib.
Question 4
1 out of 1 points
An oncology nurse is reviewing the pathophysiology of cancer and is
discussing with a colleague the factors that contribute to the success or
failure of a patient's chemotherapy. Which of the following cancerous
cells is most susceptible to the effects of chemotherapeutic drugs?
Response Cells that have a short generation time or rapid mitotic
Feedback: rate are most sensitive to antineoplastic agents. All cells
(both cancerous and noncancerous) have a blood supply.
A lack of contact inhibition is characteristic of cancer,
but this is not associated with susceptibility to
chemotherapeutic drugs.
Question 5
1 out of 1 points
A nurse is caring for a patient with cancer who has been prescribed
dronabinol (Marinol) to help reduce nausea and vomiting from
chemotherapy. The nurse will inform the patient that he or she is
taking an oral form of
Response The major ingredient of Marinol is 9-
Feedback: tetrahydrocannabinol (THC), the active ingredient in
marijuana.
Question 6
1 out of 1 points
When planning care for a patient who is receiving filgrastim
(Neupogen) for a nonmyeloid malignancy, the nurse should formulate
which of the following patient outcomes? (Select all that apply.)
